NASDAQ · LFMD
Healthcare · Medical - Pharmaceuticals
$2.23
Up+$0.09 (+4.04%)
Updated Oct 30, 2026, 1:00 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · LFMD
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 28, 2026
LFMD closed at $2.23 after 20 trading sessions, down 21.75% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 28, 2026 | $2.13 | $2.24 | $2.10 | $2.23 | 694.44K |
| Oct 27, 2026 | $2.08 | $2.165 | $2.075 | $2.12 | 997.07K |
| Oct 26, 2026 | $2.13 | $2.15 | $2.06 | $2.08 | 361.13K |
| Oct 23, 2026 | $2.17 | $2.17 | $2.105 | $2.13 | 402.08K |
| Oct 22, 2026 | $2.13 | $2.20 | $2.10 | $2.17 | 674.29K |
| Oct 21, 2026 | $2.28 | $2.28 | $2.125 | $2.14 | 628.31K |
| Oct 20, 2026 | $2.27 | $2.355 | $2.21 | $2.245 | 699.73K |
| Oct 19, 2026 | $2.35 | $2.39 | $2.225 | $2.25 | 784.41K |
| Oct 16, 2026 | $2.44 | $2.48 | $2.34 | $2.34 | 898.47K |
| Oct 15, 2026 | $2.36 | $2.495 | $2.342 | $2.46 | 737.27K |
| Oct 14, 2026 | $2.47 | $2.48 | $2.355 | $2.37 | 671.81K |
| Oct 13, 2026 | $2.55 | $2.57 | $2.46 | $2.47 | 733.39K |
| Oct 12, 2026 | $2.65 | $2.65 | $2.53 | $2.55 | 626.43K |
| Oct 9, 2026 | $2.66 | $2.675 | $2.58 | $2.63 | 620.37K |
| Oct 8, 2026 | $2.77 | $2.77 | $2.62 | $2.65 | 931.45K |
| Oct 7, 2026 | $2.70 | $2.855 | $2.6804 | $2.79 | 509.79K |
| Oct 6, 2026 | $2.75 | $2.81 | $2.71 | $2.73 | 444.53K |
| Oct 5, 2026 | $2.86 | $2.86 | $2.67 | $2.72 | 802.51K |
| Oct 2, 2026 | $2.86 | $2.94 | $2.725 | $2.74 | 709.13K |
| Oct 1, 2026 | $2.90 | $2.91 | $2.825 | $2.85 | 712.01K |
The latest Smart Investors Daily articles mentioning LFMD.
Company
Market Activity
Research & News
LFMD research
Company profile and research snapshot.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 17, 2026 | HC Wainwright & Co. | Buy | — |
| Aug 7, 2026 | HC Wainwright & Co. | Buy | — |
| Aug 6, 2026 | B. Riley Securities | Buy | — |
| Aug 6, 2026 | BTIG | Buy | — |
| May 26, 2026 | HC Wainwright & Co. | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 26, 2026
Medifast (NYSE:MED) reported third-quarter 2026 revenue of $72 million, down 19.4% from a year earlier, as the company continued to face a sharp decline in its active earning coach base. Management said revenue was within its guidance range and marked a fourth consecutive quarter in which sales stab
Yahoo · Oct 20, 2026
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, announces that it will report financial results for the three and nine months ended September 30, 2026, before the open of the U.S. financial markets on November 9, 2026, and will host a conference call beginning at 8:30 a.m. Eastern time. Conference Call & Webcast Details Date:Monday, November 9thTime:8:30 a.m. Eastern timeToll-Free Dial-In:(877) 270-2148Int
Yahoo · Sep 22, 2026
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on October 15, 2026, to holders of record at the close of business on October 2, 2026. About LifeMD, Inc. LifeMD® is a le
Yahoo · Sep 20, 2026
LifeMD, Inc. (NASDAQ:LFMD) announced an exclusive healthcare collaboration on September 15 that initially makes virtual-health membership benefits available to approximately 29 million eligible AT&T wireless and fiber customers across 11 states. Customers must be 18 or older, and some services have additional eligibility and state restrictions. A nationwide expansion planned for January 2027 would extend […]
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning LFMD.
